Zazen Pharma Private Limited, a active private limited company, was established on 12 June 1997 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1997PTC108726. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Rupal Haresh Mehta (Director), Mehul Haresh Mehta (Director). Past directors included Dinesh Chand Agarwal, Rupal Haresh Mehta, Niraj Harshad Dholakiya. It holds ₹47.45 Cr open charges and ₹3.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 302 Adinath Apt51 Tps Road Plot No 152 Borivli(W), Mumbai, Maharashtra, 400092.
U24230MH1997PTC108726
108726
12 June 1997
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Zazen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rupal Haresh Mehta | Director | 16 Apr 2021 | Current |
| Mehul Haresh Mehta | Director | 12 Jun 1997 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 03 Oct 2006 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 16 Apr 2021 | Past |
| Pramod Abcsdd | Director | 13 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zazen Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 82.71% increase. The company also saw a substantial improvement in profitability, with a 88.45% increase in profit. The company's net worth Soared by an impressive increase of 328.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Zazen Pharma had a public holding of 38.49%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹474,541,173.00
₹38,280,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2025 | State Bank Of India | ₹34.75 Cr | Open |
| 26 May 2025 | Others | ₹4.00 Cr | Open |
| 21 Jan 2025 | Others | ₹2.23 Cr | Open |
| 27 Nov 2024 | Others | ₹1.64 M | Open |
| 18 Nov 2024 | Others | ₹0.35 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Zazen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zazen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zazen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with State Bank Of India amounted to Rs. 347.50 M with Charge ID 101155051 was registered on 02 Jun 2025. was documented.
A charge with Others amounted to Rs. 40.00 M with Charge ID 101103403 was registered on 26 May 2025. was recorded as a recent event.
A charge with Others of Rs. 22.30 M registered on 21 Jan 2025 with Charge ID 101044023 was modified on 23 Jan 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 22.30 M with Charge ID 101044023 was registered on 21 Jan 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 1.64 M with Charge ID 101019238 was registered on 27 Nov 2024. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.35 M with Charge ID 101013631 was registered on 18 Nov 2024. was documented.
The CIN of Zazen Pharma Private Limited is U24230MH1997PTC108726.
Zazen Pharma Private Limited is headquartered at 302 Adinath Apt51 Tps Road Plot No 152 Borivli(W), Mumbai, Maharashtra, 400092.
Zazen Pharma Private Limited was incorporated on 12 June 1997.
The current directors of Zazen Pharma Private Limited are
The primary industry of Zazen Pharma Private Limited is Manufacturing.
Zazen Pharma Private Limited is unlisted.
The authorized capital of Zazen Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Zazen Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX